Covishield 3rd dose increases antibody response against Omicron: Study
A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant, according to a new trial published by the British-Swedish drugmaker on Thursday.
The trial showed the third dose booster also increases the immune response to Beta, Delta, Alpha, and Gamma SARS-CoV-2 variants.
For more information check out the full story on the link below:
Covishield 3rd dose increases antibody response against Omicron, says Study
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.